Compare IDEXX Laboratories, Inc. (IDXX) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs LTC Properties Inc — how do they compare? IDEXX Laboratories, Inc. trades at $517.55 (market cap $40.43B), while LTC Properties Inc trades at $42.35 (market cap $2.27B). The key difference: IDEXX Laboratories, Inc. is far larger — about 17.8× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.42% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and LTC Properties Inc for 89 Days on average.
| IDXX | LTC | |
|---|---|---|
Market Cap | $40.43B | $2.27B |
Volume | 692,164 | 574,171 |
Sector | Health | Real Estate |
52-Week High | $766.68 | $43.50 |
52-Week Low | $504.70 | $33.98 |
Typical Hold Time | 46 Days | 89 Days |
Enterprise Value | $41.32B | $3.01B |
Dividend Yield | — | 5.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $517.47, up 2.13% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and expanded diagnostic platforms highlight growth initiatives, while analyst consensus remains bullish with a $665 price target representing 28.5% upside potential.
The outlook remains positive given consistent earnings beats and expanding veterinary diagnostics market share. Key risks include FX headwinds, weaker U.S. vet visits, and premium valuations at 36x P/E. Institutional ownership trends show mixed activity with recent insider selling, but long-term growth drivers in pet healthcare innovation support the bullish analyst stance.
LTC Properties trades at $42.37, up 1.34% with a bullish technical signal. The REIT shows strong fundamentals with 2025 revenue of $262.85M and net income of $117.97M, delivering a 38.93% net margin. Recent acquisitions totaling $360M accelerate the SHOP portfolio transition, while consistent monthly dividends of $0.19 provide income stability. Analyst consensus sits at $49.67 with mixed ratings (7 Buy, 12 Hold, 3 Sell) amid strategic shifts.
Outlook remains positive due to demographic tailwinds in senior housing, though rising rates and execution risks on $730M asset sales pose challenges. Current valuation at P/E 15.02 appears reasonable for growth prospects, with technical support at $41-42 offering near-term stability. The stock presents a balanced opportunity for income and growth investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
